In the laboratory of the European Medical Center, biochemical studies of blood, urine and cerebrospinal fluid are performed using automatic biochemical analyzers ABXPENTRA 400 (Horiba AVXAS, France) and an analyzer of the Olympus-AU480 family (Beckman Coulter, USA).
The list of biochemical parameters consists of more than 100 parameters and allows for the study of markers of diseases of organs and systems such as the liver, kidneys, cardiovascular system, markers of bone metabolism, anemia, specific inflammatory proteins, electrolyte composition, etc.
The use of devices of this class guarantees the accuracy of the results obtained, and daily quality control and the results of external quality control eliminate errors in the analytical stage.
We are responsible for the quality of our work, so we carefully monitor not only the research process itself, but also the quality of the biomaterial submitted for research. A special test is used to determine the quality of the test material: the presence of lipemia, ictericity and hemolysis of the sample with an assessment of their effect on the test results.
The quality of research is achieved not only through the use of the latest equipment and reagents, but also through the organization of the preanalytical stage at the European Medical Center. It takes no more than 1 hour from the moment of collecting the material to the start of the study.
Diabetes is diagnosed and monitored by determining glycosylated hemoglobin on the D-10 Hemoglobin Testing System analyzer. The manufacturer of the device and reagents is Bio Rad, USA. The method is based on high-performance liquid chromatography. The liquid chromatography method is recognized as an international reference method for the determination of glycosylated hemoglobin. The device has been tested in accordance with the NGSP standard, which guarantees the accuracy of the results obtained.
.webp)
.webp)
.webp)
